1. Staurosporine-induced apoptosis is independent of p16 and p21 and achieved via arrest at G2/M and at G1 in U251MG human glioma cell line

   • Fumiyuki Yamasaki
   • Seiji Hama
   • Kaoru Kurisu

   Original Article 20 March 2003 Pages: 271 - 283

   

2. Tamoxifen induces apoptosis in Fas⁺ tumor cells by upregulating the expression of Fas ligand

   • Nisha Nagarkatti
   • Barbara A. Davis

   Original Article 27 March 2003 Pages: 284 - 290

   

3. The schedule-dependent effects of etoposide in leukaemic cell lines: a function of concentration and duration

   • Wai M. Liu
   • Simon P. Joel

   Original Article 05 March 2003 Pages: 291 - 296

   

4. Safety and efficacy of the MDR inhibitor Incel (biricodar, VX-710) in combination with mitoxantrone and prednisone in hormone-refractory prostate cancer

   • Randall P. Rago
   • Albert Einstein Jr.
   • William S. Dalton

   Original Article 13 March 2003 Pages: 297 - 305

   

5. The cardioprotector monoHER does not interfere with the pharmacokinetics or the metabolism of the cardiotoxic agent doxorubicin in mice

   • Mohamed A. I. Abou El Hassan
   • Marc A. Kedde
   • Wim J. F. van der Vijgh

   Original Article 22 March 2003 Pages: 306 - 310

   

6. High-dose methotrexate: on the relationship of methotrexate elimination time vs renal function and serum methotrexate levels in 1164 courses in 264 Swedish children with acute lymphoblastic leukaemia (ALL)

   • T. Skärby
   • P. Jönsson
   • P. Höglund

   Original Article 28 March 2003 Pages: 311 - 320

   

7. Circulating angiogenic growth factor levels in mice bearing human tumors using Luminex Multiplex technology

   • Kristan A. Keyes
   • Larry Mann
   • Beverly A. Teicher

   Original Article 18 March 2003 Pages: 321 - 327

   

8. Gemcitabine pharmacokinetics and interaction with paclitaxel in patients with advanced non-small-cell lung cancer

   • Stacy S. Shord
   • Stephanie R. Faucette
   • Celeste Lindley

   Original Article 13 March 2003 Pages: 328 - 336

   

9. Cell cycle-dependent potentiation of cisplatin by UCN-01 in non-small-cell lung carcinoma

   • Philip C. Mack
   • David R. Gandara
   • Paul H. Gumerlock

   Original Article 25 March 2003 Pages: 337 - 348

   

10. Oxygen-15 positron-emission tomography for predicting selective delivery of a chemotherapeutic agent to hepatic cancers during angiotensin II-induced hypertension

    • Toshimori Koh
    • Hiroki Taniguchi
    • Hisakazu Yamagishi

    Original Article 05 March 2003 Pages: 349 - 358

    

11. Bleomycin-mediated electrochemotherapy in mouse NR-S1 carcinoma

    • Akira Kitamura

    Short Communication 21 March 2003 Pages: 359 - 362